NEXGEL, INC.
NXGLWNasdaq
$0.03
↓ -0.4%Jul 17 close · end-of-day
Price
1Y↓ -91.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$214,129.75
Enterprise Value
$777,129.75
P/E
—
P/S
0.0
P/B
0.1
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$11.3M
Net Income (TTM)
-$3.2M
Free Cash Flow (TTM)
—
Gross Margin
38.9%
Operating Margin
-31.4%
Net Margin
-28.5%
ROE
-80.5%
ROIC
-61.3%
Debt / Equity
0.1
Net Cash
-$563,000.00
Return 1Y
-92.0%
Company profile
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded in 1997 and is based in Langhorne, Pennsylvania.
- CEO
- Adam D. Levy
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 10
- Headquarters
- Pennsylvania
- Website
- nexgel.com
Earnings
NXGLW Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$2.6M↓ -5.6%
Diluted EPS-$0.11↑ +22.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $674,000.00 | $1.6M | $2.0M | $4.1M | $8.7M | $11.4M |
| Gross profit | -$291,000.00 | $8,000.00 | $256,000.00 | $374,000.00 | $2.7M | $4.5M |
| Operating income | -$2.3M | -$2.6M | -$3.3M | -$3.5M | -$3.6M | -$3.4M |
| Net income | -$2.3M | -$4.3M | -$4.7M | -$3.2M | -$3.3M | -$3.0M |
| Diluted EPS | -$1.05 | -$1.45 | -$0.85 | -$0.56 | -$0.50 | -$0.38 |
| Operating cash flow | -$1.8M | -$2.8M | -$3.0M | -$3.2M | -$3.9M | -$1.3M |
| Free cash flow | -$2.1M | -$3.0M | -$3.1M | -$3.9M | -$4.3M | -$1.4M |
| Gross margin | -43.2% | 0.5% | 12.5% | 9.1% | 31.6% | 39.5% |
| Operating margin | -335.3% | -165.7% | -163.5% | -85.0% | -40.9% | -29.3% |
| Net margin | -335.9% | -277.9% | -231.7% | -77.2% | -37.8% | -26.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | $2.9M | $3.0M | $2.8M | $2.9M | $2.9M | $2.8M | $2.6M |
| Gross profit | $293,000.00 | $1.2M | $1.1M | $1.2M | $1.3M | $1.2M | $820,000.00 | $1.1M |
| Operating income | -$1.1M | -$788,000.00 | -$841,000.00 | -$777,000.00 | -$636,000.00 | -$725,000.00 | -$1.2M | -$958,000.00 |
| Net income | -$885,000.00 | -$693,000.00 | -$850,000.00 | -$712,000.00 | -$665,000.00 | -$653,000.00 | -$970,000.00 | -$927,000.00 |
| Diluted EPS | -$0.14 | -$0.11 | -$0.11 | -$0.09 | -$0.09 | -$0.08 | -$0.12 | -$0.11 |
| Operating cash flow | -$700,000.00 | -$1.2M | -$859,000.00 | -$400,000.00 | -$407,000.00 | -$785,000.00 | $281,000.00 | -$504,000.00 |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 20.3% | 39.3% | 37.5% | 42.3% | 43.6% | 42.4% | 29.3% | 40.0% |
| Operating margin | -73.2% | -26.8% | -27.6% | -27.7% | -22.1% | -24.7% | -43.4% | -36.2% |
| Net margin | -61.5% | -23.6% | -27.9% | -25.4% | -23.1% | -22.3% | -34.7% | -35.0% |
Company news
Jun 4, 2026
May 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-23 | Levy Adam R.· Chief Executive Officer | Sale | 5,000 | $0.59 | $2,966.50 | filing |
| 2026-06-18 | Levy Adam R.· Chief Executive Officer | Sale | 6,000 | $0.59 | $3,552.60 | filing |
| 2026-06-11 | Levy Adam R.· Chief Executive Officer | Sale | 3,000 | $0.61 | $1,840.80 | filing |
| 2026-06-08 | Levy Adam R.· Chief Executive Officer | Sale | 3,000 | $0.55 | $1,641.00 | filing |
| 2026-06-04 | Levy Adam R.· Chief Executive Officer | Sale | 3,000 | $0.59 | $1,780.80 | filing |
| 2026-06-01 | Levy Adam R.· Chief Executive Officer | Sale | 2,000 | $0.59 | $1,171.80 | filing |
| 2026-05-29 | Levy Adam R.· Chief Executive Officer | Sale | 3,000 | $0.60 | $1,800.90 | filing |
| 2026-05-28 | Levy Adam R.· Chief Executive Officer | Sale | 7,000 | $0.61 | $4,240.60 | filing |
| 2026-05-27 | Levy Adam R.· Chief Executive Officer | Sale | 3,000 | $0.60 | $1,792.50 | filing |
| 2025-12-24 | Levy Adam R.· Chief Executive Officer | Sale | 4,000 | $1.57 | $6,286.40 | filing |
| 2025-12-22 | Levy Adam R.· Chief Executive Officer | Sale | 6,000 | $1.61 | $9,660.60 | filing |
| 2025-11-06 | Levy Adam R.· Chief Executive Officer | Sale | 4,000 | $2.52 | $10,084.40 | filing |
| 2025-10-03 | Henry Scott Robert | Sale | 7,175 | $2.55 | $18,297.69 | filing |
| 2025-10-03 | Levy Adam R.· Chief Executive Officer | Sale | 2,400 | $2.55 | $6,119.28 | filing |
| 2025-10-02 | Levy Adam R.· Chief Executive Officer | Sale | 1,600 | $2.50 | $4,000.00 | filing |
| 2025-10-02 | Henry Scott Robert | Sale | 825 | $2.50 | $2,062.50 | filing |
| 2025-09-25 | Henry Scott Robert | Sale | 7,697 | $2.36 | $18,148.76 | filing |
| 2025-08-28 | Levy Adam R.· Chief Executive Officer | Sale | 4,000 | $2.47 | $9,896.40 | filing |
Latest 18 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.